ENTRY       D00364                      Drug
NAME        Loratadine (JAN/USP/INN);
            Claritin (TN)
PRODUCT
  GENERIC   LORATADINE (Bryant Ranch Prepack)
FORMULA     C22H23ClN2O2
EXACT_MASS  382.1448
MOL_WEIGHT  382.8832
CLASS       Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
            Dermatological agent
             DG03243  Atopic dermatitis agent
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 4490
            ATC code: R06AX13
            Product: D00364<JP/US>
EFFICACY    Antiallergic, H1 receptor antagonist
TARGET      HRH1 [HSA:3269] [KO:K04149]
  PATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction
            hsa04750(3269)  Inflammatory mediator regulation of TRP channels
METABOLISM  Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07212  Histamine H1 receptor antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R06 ANTIHISTAMINES FOR SYSTEMIC USE
               R06A ANTIHISTAMINES FOR SYSTEMIC USE
                R06AX Other antihistamines for systemic use
                 R06AX13 Loratadine
                  D00364  Loratadine (JAN/USP/INN) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              44  Allergic agents
               449  Miscellaneous
                4490  Miscellaneous
                 D00364  Loratadine (JAN/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Second-class OTC drugs
              Inorganic and organic chemicals
               Loratadine
                D00364  Loratadine (JAN/USP/INN)
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                D00364  Loratadine
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00364  Loratadine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               D00364  Loratadine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D00364  Loratadine
            Drug classes [BR:br08332]
             Anti-allergic agent
              DG01482  Histamine receptor H1 antagonist
               D00364  Loratadine
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00364  Loratadine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH1
                 D00364  Loratadine (JAN/USP/INN) &lt;JP/US&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00364
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00364
            Rx-to-OTC switch list in the USA [br08315.html]
             D00364
            Rx-to-OTC switch list in Japan [br08314.html]
             D00364
DBLINKS     CAS: 79794-75-5
            PubChem: 7847430
            ChEBI: 6538
            LigandBox: D00364
            NIKKAJI: J23.749C
ATOM        27
            1   C1x C    14.9552  -13.2773
            2   C8y C    14.1108  -12.1647
            3   C8y C    14.4469  -10.8042
            4   C2y C    15.7114  -10.2245
            5   C1x C    16.3648  -13.3026
            6   C8y C    16.9683  -10.8485
            7   C8y C    17.2556  -12.2210
            8   C8x C    13.4370   -9.8331
            9   C8x C    12.0914  -10.2223
            10  C8y C    11.7553  -11.5828
            11  C8x C    12.7651  -12.5536
            12  C8x C    18.5904  -12.6593
            13  C8x C    19.6375  -11.7223
            14  C8x C    19.3504  -10.3498
            15  N5x N    18.0153   -9.9115
            16  C2y C    15.6631   -8.8458
            17  X   Cl   10.4237  -11.9675
            18  C1x C    16.8756   -8.1458
            19  C1x C    16.8756   -6.7458
            20  N1y N    15.6631   -6.0458
            21  C1x C    14.4507   -6.7458
            22  C1x C    14.4507   -8.1458
            23  C7a C    15.6628   -4.6201
            24  O6a O    14.4631   -3.9277
            25  O7a O    16.8880   -3.9123
            26  C1b C    18.0903   -4.6062
            27  C1a C    19.2739   -3.9225
BOND        30
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     3   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    2  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    6  15 2
            18    4  16 2
            19   10  17 1
            20   16  18 1
            21   18  19 1
            22   19  20 1
            23   20  21 1
            24   21  22 1
            25   16  22 1
            26   20  23 1
            27   23  24 2
            28   23  25 1
            29   25  26 1
            30   26  27 1
///
